ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BIOL Biolase Inc

0.1499
0.0015 (1.01%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biolase Inc NASDAQ:BIOL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0015 1.01% 0.1499 0.12 0.21 0.1498 0.1421 0.1488 736,146 05:00:09

BIOLASE, Inc to Report Second Quarter 2022 Results on August 11, 2022

28/07/2022 11:30am

PR Newswire (US)


Biolase (NASDAQ:BIOL)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Biolase Charts.

LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

To access the live call, dial 877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following earnings code: 838343.

A live and archived webcast of the conference call will be accessible on the BIOLASE Investor Relations Page. In addition, a phone replay will be available approximately two hours following the end of the call, and it will remain available for one week. To access the call replay dial 877-481-4010 or +1 919-882-2331 (International) and enter replay passcode: 46222.

About BIOLASE

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 302 patented and 31 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Contacts:
EVC Group, Inc.
Michael Polyviou/Todd Kehrli
(732) 232-6914
mpolyviou@evcgroup.com; tkehrli@evcgroup.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-inc-to-report-second-quarter-2022-results-on-august-11-2022-301594613.html

SOURCE BIOLASE, Inc.

Copyright 2022 PR Newswire

1 Year Biolase Chart

1 Year Biolase Chart

1 Month Biolase Chart

1 Month Biolase Chart

Your Recent History

Delayed Upgrade Clock